M&A Deal Summary |
|
|---|---|
| Date | 2015-03-16 |
| Target | Pulmatrix Operating Co. |
| Sector | Life Science |
| Buyer(s) | Pulmatrix |
| Deal Type | Merger |
| Advisor(s) | Palladium Capital Group (Financial) |
SEARCH BY
| Category | Company |
|---|---|
| Founded | 2003 |
| Sector | Life Science |
| Employees | 22 |
| Revenue | 8M USD (2024) |
Pulmatrix is a clinical-stage biopharmaceutical company developing innovative inhaled therapies to address serious pulmonary disease using its patented iSPERSE technology. Pulmatrix was founded in 2003 and is based in Bedford, Massachusetts.
| DEAL STATS | # |
|---|---|
| Overall | 1 of 1 |
| Sector: Life Science M&A | 1 of 1 |
| Type: Merger M&A Deals | 1 of 1 |
| State: Massachusetts M&A | 1 of 1 |
| Country: United States M&A | 1 of 1 |
| Year: 2015 M&A | 1 of 1 |